SG Americas Securities’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-15,887
Closed -$46K – 3351
2025
Q4
$46K Buy
+15,887
New +$44K ﹤0.01% 3370
2025
Q2
– Sell
-22,126
Closed -$64K – 3088
2025
Q1
$64K Sell
22,126
-5,063
-19% -$20.5K ﹤0.01% 3182
2024
Q4
$112K Buy
27,189
+8,387
+45% +$36.7K ﹤0.01% 2648
2024
Q3
$84K Buy
+18,802
New +$88.2K ﹤0.01% 3123
2024
Q1
– Sell
-18,802
Closed -$187K – 3070
2023
Q4
$187K Buy
18,802
+4,342
+30% +$34.1K ﹤0.01% 2224
2023
Q3
$116K Buy
+14,460
New +$145K ﹤0.01% 2694

Other funds holding DH

SG Americas Securities's DH Position: Q1 2026 in Review

SG Americas Securities sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 15,887 shares — an estimated $46K sold.

SG Americas Securities first reported a position in DH in Q3 2023 and held it in 6 quarters. The position peaked at $187K in Q4 2023. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • SG Americas Securities reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 15,887 Definitive Healthcare shares in Q1 2026, an estimated $46K.
  • SG Americas Securities first reported a position in Definitive Healthcare in Q3 2023 and held it in 6 quarters.
  • SG Americas Securities's Definitive Healthcare position peaked at $187K in Q4 2023.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.